title: Expert recommendations for the laboratory diagnosis of MPS VI.
abstract: Mucopolysaccharidosis VI (MPS VI) is a lysosomal storage disease caused by a deficiency of N-acetylgalactosamine 4-sulfatase (arylsulfatase B, ASB). This enzyme is required for the degradation of dermatan sulfate. In its absence, dermatan sulfate accumulates in cells and is excreted in large quantities in urine. Specific therapeutic intervention is available; however, accurate and timely diagnosis is crucial for maximal benefit. To better understand the current practices for diagnosis and to establish diagnostic guidelines, an international MPS VI laboratory diagnostics scientific summit was held in February of 2011 in Miami, Florida. The various steps in the diagnosis of MPS VI were discussed including urinary glycosaminoglycan (uGAG) analysis, enzyme activity analysis, and molecular analysis. The following conclusions were reached. Dilute urine samples pose a significant problem for uGAG analysis and MPS VI patients can be missed by quantitative uGAG testing alone as dermatan sulfate may not always be excreted in large quantities. Enzyme activity analysis is universally acknowledged as a key component of diagnosis; however, several caveats must be considered and the appropriate use of reference enzymes is essential. Molecular analysis supports enzyme activity test results and is essential for carrier testing, subsequent genetic counseling, and prenatal testing. Overall the expert panel recommends caution in the use of uGAG screening alone to rule out or confirm the diagnosis of MPS VI and acknowledges enzyme activity analysis as a critical component of diagnosis. Measurement of another sulfatase enzyme to exclude multiple sulfatase deficiency was recommended prior to the initiation of therapy. When feasible, the use of molecular testing as part of the diagnosis is encouraged. A diagnostic algorithm for MPS VI is provided.
authors.affiliation: Biochemical Genetics Laboratory at Greenwood Genetic Center, Greenwood, SC, USA. tim@ggc.org
authors.forename: T
authors.initials: T
authors.lastname: Wood
authors.forename: O A
authors.initials: OA
authors.lastname: Bodamer
authors.forename: M G
authors.initials: MG
authors.lastname: Burin
authors.forename: V
authors.initials: V
authors.lastname: D'Almeida
authors.forename: M
authors.initials: M
authors.lastname: Fietz
authors.forename: R
authors.initials: R
authors.lastname: Giugliani
authors.forename: S M
authors.initials: SM
authors.lastname: Hawley
authors.forename: C J
authors.initials: CJ
authors.lastname: Hendriksz
authors.forename: W L
authors.initials: WL
authors.lastname: Hwu
authors.forename: D
authors.initials: D
authors.lastname: Ketteridge
authors.forename: Z
authors.initials: Z
authors.lastname: Lukacs
authors.forename: N J
authors.initials: NJ
authors.lastname: Mendelsohn
authors.forename: N
authors.initials: N
authors.lastname: Miller
authors.forename: M
authors.initials: M
authors.lastname: Pasquali
authors.forename: A
authors.initials: A
authors.lastname: Schenone
authors.forename: K
authors.initials: K
authors.lastname: Schoonderwoerd
authors.forename: B
authors.initials: B
authors.lastname: Winchester
authors.forename: P
authors.initials: P
authors.lastname: Harmatz
mesh_terms: D002553:Cerebroside-Sulfatase / Q000097:blood / Q000652:urine; D059788:Dried Blood Spot Testing; D006025:Glycosaminoglycans / Q000652:urine*; D006801:Humans; D009087:Mucopolysaccharidosis VI / Q000175:diagnosis* / Q000201:enzymology; D020051:N-Acetylgalactosamine-4-Sulfatase / Q000097:blood / Q000235:genetics / Q000652:urine
chemical_list: D006025:Glycosaminoglycans; D020051:N-Acetylgalactosamine-4-Sulfatase; D002553:Cerebroside-Sulfatase